Literature DB >> 17459586

Mast cell degranulation activates a pain pathway underlying migraine headache.

Dan Levy1, Rami Burstein, Vanessa Kainz, Moshe Jakubowski, Andrew M Strassman.   

Abstract

Intracranial headaches such as that of migraine are generally accepted to be mediated by prolonged activation of meningeal nociceptors but the mechanisms responsible for such nociceptor activation are poorly understood. In this study, we examined the hypothesis that meningeal nociceptors can be activated locally through a neuroimmune interaction with resident mast cells, granulated immune cells that densely populate the dura mater. Using in vivo electrophysiological single unit recording of meningeal nociceptors in the rat we observed that degranulation of dural mast cells using intraperitoneal administration of the basic secretagogue agent compound 48/80 (2 mg/kg) induced a prolonged state of excitation in meningeal nociceptors. Such activation was accompanied by increased expression of the phosphorylated form of the extracellular signal-regulated kinase (pERK), an anatomical marker for nociceptor activation. Mast cell-induced nociceptor interaction was also associated with downstream activation of the spinal trigeminal nucleus as indicated by an increase in c-fos expression. Our findings provide evidence linking dural mast cell degranulation to prolonged activation of the trigeminal pain pathway believed to underlie intracranial headaches such as that of migraine.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459586      PMCID: PMC2045157          DOI: 10.1016/j.pain.2007.03.012

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  46 in total

1.  Catecholaminergic and acetylcholine esterase containing nerves of cranial and spinal dura mater in humans and rodents.

Authors:  M Artico; C Cavallotti
Journal:  Microsc Res Tech       Date:  2001-05-01       Impact factor: 2.769

2.  Mast cell mediators other than histamine induce pruritus in atopic dermatitis patients: a dermal microdialysis study.

Authors:  R Rukwied; G Lischetzki; F McGlone; G Heyer; M Schmelz
Journal:  Br J Dermatol       Date:  2000-06       Impact factor: 9.302

3.  Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice.

Authors:  R A Ribeiro; M L Vale; S M Thomazzi; A B Paschoalato; S Poole; S H Ferreira; F Q Cunha
Journal:  Eur J Pharmacol       Date:  2000-01-03       Impact factor: 4.432

4.  Gi-mediated activation of the Syk kinase by the receptor mimetic basic secretagogues of mast cells: role in mediating arachidonic acid/metabolites release.

Authors:  I Shefler; R Sagi-Eisenberg
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo.

Authors:  J J Rozniecki; V Dimitriadou; M Lambracht-Hall; X Pang; T C Theoharides
Journal:  Brain Res       Date:  1999-12-04       Impact factor: 3.252

6.  Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.

Authors:  Hayrunnisa Bolay; Uwe Reuter; Andrew K Dunn; Zhihong Huang; David A Boas; Michael A Moskowitz
Journal:  Nat Med       Date:  2002-02       Impact factor: 53.440

7.  Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors.

Authors:  D Levy; A M Strassman
Journal:  J Physiol       Date:  2002-01-15       Impact factor: 5.182

8.  A neurohistochemical blueprint for pain-induced loss of appetite.

Authors:  A Malick; M Jakubowski; J K Elmquist; C B Saper; R Burstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

9.  Sensitization to mechanical stimulation by inflammatory mediators and by mild burn in canine visceral nociceptors in vitro.

Authors:  Hisashi Koda; Kazue Mizumura
Journal:  J Neurophysiol       Date:  2002-04       Impact factor: 2.714

10.  Montelukast in the prophylaxis of migraine: a potential role for leukotriene modifiers.

Authors:  F Sheftell; A Rapoport; R Weeks; B Walker; I Gammerman; S Baskin
Journal:  Headache       Date:  2000-02       Impact factor: 5.887

View more
  119 in total

1.  Cutaneous nociception and neurogenic inflammation evoked by PACAP38 and VIP.

Authors:  Henrik Winther Schytz; Helle Holst; Lars Arendt-Nielsen; Jes Olesen; Messoud Ashina
Journal:  J Headache Pain       Date:  2010-05-09       Impact factor: 7.277

2.  Ionic mechanisms underlying inflammatory mediator-induced sensitization of dural afferents.

Authors:  Andrea H Vaughn; Michael S Gold
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

3.  pH-evoked dural afferent signaling is mediated by ASIC3 and is sensitized by mast cell mediators.

Authors:  Jin Yan; Xiaomei Wei; Christina Bischoff; Rebecca M Edelmayer; Gregory Dussor
Journal:  Headache       Date:  2013-06-28       Impact factor: 5.887

4.  Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models.

Authors:  Amanda Avona; Carolina Burgos-Vega; Michael D Burton; Armen N Akopian; Theodore J Price; Gregory Dussor
Journal:  J Neurosci       Date:  2019-04-08       Impact factor: 6.167

5.  Sex differences in the inflammatory mediator-induced sensitization of dural afferents.

Authors:  N N Scheff; M S Gold
Journal:  J Neurophysiol       Date:  2011-07-13       Impact factor: 2.714

6.  Dural afferents express acid-sensing ion channels: a role for decreased meningeal pH in migraine headache.

Authors:  Jin Yan; Rebecca M Edelmayer; Xiaomei Wei; Milena De Felice; Frank Porreca; Gregory Dussor
Journal:  Pain       Date:  2010-10-23       Impact factor: 6.961

7.  Developmental changes of mast cell populations in the cerebral meninges of the rat.

Authors:  Helen Michaloudi; Christos Batzios; Maria Chiotelli; Georgios C Papadopoulos
Journal:  J Anat       Date:  2007-09-06       Impact factor: 2.610

8.  Evidence for the modulation of nociception in mice by central mast cells.

Authors:  C L Kissel; K J Kovács; A A Larson
Journal:  Eur J Pain       Date:  2017-07-19       Impact factor: 3.931

Review 9.  CGRP and migraine: could PACAP play a role too?

Authors:  Eric A Kaiser; Andrew F Russo
Journal:  Neuropeptides       Date:  2013-10-23       Impact factor: 3.286

Review 10.  Therapeutic use of botulinum toxin in migraine: mechanisms of action.

Authors:  Roshni Ramachandran; Tony L Yaksh
Journal:  Br J Pharmacol       Date:  2014-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.